The vulvar cancer drugs market is estimated to be valued at USD 0.640 Bn in 2024 and is expected to reach USD 1.131 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8.47% from 2024 to 2031. https://www.writerscafe.org/kajalpatil/blogs/Vulvar-Cancer-Drugs-Market-is-Anticipated-to-Witness-High-Growth-Owing-to-Increasing-Prevalence-of-Vulvar-Cancer/244650/